Correspondence 0001437749-25-009277 from GenEmbryomics Ltd (CIK 0002038033)
GenEmbryomics Ltd (CIK 0002038033)
Date: March 26, 2025 · CIK: 0002038033 · Accession: 0001437749-25-009277
AI Filing Summary & Sentiment
File numbers found in text: 333-285074
Letter
gene20250325_corresp.htm
March 26, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Robert Augustin and Jane Park
Tracey Houser and Li Xiao
Division of Corporate Finance
Office of Industrial Applications and Services
Re:
GenEmbryomics Limited
Registration Statement on Form F-1, as amended
File No. 333-285074
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, GenEmbryomics Limited (the “Registrant”) hereby respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that it will be declared effective at 9:00 a.m., Eastern Time, on Friday, March 28, 2025, or as soon thereafter as is practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the U.S. Securities and Exchange Commission. The Registrant hereby authorizes Fox Rothschild LLP, counsel to the Registrant, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to Sarah Hewitt of Fox Rothschild LLP at (212) 878-1435.
Thank you for your assistance in this matter. Should you have any questions, please call Ms. Hewitt.
Very truly yours,
/s/ Nicholas Murphy
Show Raw Text
CORRESP 1 filename1.htm gene20250325_corresp.htm March 26, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Robert Augustin and Jane Park Tracey Houser and Li Xiao Division of Corporate Finance Office of Industrial Applications and Services Re: GenEmbryomics Limited Registration Statement on Form F-1, as amended File No. 333-285074 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, GenEmbryomics Limited (the “Registrant”) hereby respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that it will be declared effective at 9:00 a.m., Eastern Time, on Friday, March 28, 2025, or as soon thereafter as is practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the U.S. Securities and Exchange Commission. The Registrant hereby authorizes Fox Rothschild LLP, counsel to the Registrant, to orally modify or withdraw this request for acceleration. The Registrant requests that it be notified of such effectiveness by a telephone call to Sarah Hewitt of Fox Rothschild LLP at (212) 878-1435. Thank you for your assistance in this matter. Should you have any questions, please call Ms. Hewitt. Very truly yours, /s/ Nicholas Murphy Nicholas Murphy Chief Executive Officer and Managing Director cc: Sarah Hewitt Esq.